Currently out of the existing stock ratings of Jason Wittes, 69 are a BUY (83.13%), 14 are a HOLD (16.87%).

Jason Wittes

Work Performance Price Targets & Ratings Chart

Analyst Jason Wittes, currently employed carries an average stock price target met ratio of 47.39% that have a potential upside of 27.33% achieved within 117 days. Previously, Jason Wittes worked at NORTHLAND CAPITAL MARKETS, AEGIS, BREAN.

Jason Wittes’s has documented 156 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on OFIX, Orthofix Medical at 08-Nov-2024.

Wall Street Analyst Jason Wittes

Analyst best performing recommendations are on LMAT (LEMAITRE VASCULAR).
The best stock recommendation documented was for LMAT (LEMAITRE VASCULAR) at 7/29/2015. The price target of $13 was fulfilled within 2 days with a profit of $1.32 (11.3%) receiving and performance score of 56.51.

Average potential price target upside

of $40.69 (17.73%) on SYK (STRYKER).
of $18.22 (17.08%) on TFX (TELEFLEX ORPORATED).
of $14.48 (12.34%) on ZBH (ZIMMER BIOMET HOLDINGS).

ARAY Accuray orporated ATEC Alphatec Holdings GMED Globus Medical STXS Stereotaxis SYK Stryker TFX Teleflex orporated ZBH Zimmer Biomet Holdings VAR Varian Medical Systems BWAY Brainsway Ltd NUVA NuVasive NVCR Novocure Ltd MASI Masimo CLDX Celldex Therapeutics LMAT LeMaitre Vascular MDWD Mediwound Ltd PGNX Progenics Pharmaceuticals ENOV Enovis Corp OFIX Orthofix Medical

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Jason Wittes (LOOP CAPITAL)